Hypoxia-induced cell stemness leads to drug resistance and poor prognosis in lung adenocarcinoma

Our findings indicate that chemical hypoxia may augment cancer cell stemness and drug resistance in CD166-positive stem cells. Therefore, targeting the stem-like cell population, especially CD166-positive cells, may represent a novel therapeutic strategy to treat lung cancer.